Interview with Andreas Windischbauer, CEO, Herba Chemosan
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Address: Haidestraße 4, 1110 Vienna,Austria
Tel: +43 1 401 04-0
Web: http://www.herba-chemosan.at/de/home/index.jsp
The Herba Apotheker-AG, with a market share of 43% not only the leading pharmaceutical wholesaler and service provider in Austria, but also has the highest level of dynamics. Seven companies form over Austria’s densest logistics network for the provision of drugs and health products. They guarantee fast operations and simplified work processes and thus for better quality control and higher deliverability. But the stock range comprises more than 42,000 articles. Several times a day we serve over 1,000 pharmacies, doctors and hospitals. In addition, the Herba Group offers its customers to support a comprehensive portfolio of services in the areas of marketing and organization. Nearly 1,000 employees contribute to the success of the company. Since 2000, the Herba Apotheker-AG is part of the German Celesio AG based in Stuttgart, whose majority shareholder is the Franz HANIEL jr. GmbH , headquartered in Duisburg.
Herba is the industry leader in pharmaceutical distribution. Almost every second drug that is delivered in an Austrian chemist on Tara, comes from one of our seven distribution centers. In addition to the largest assortment of drugs and health products, we offer our customers special ranges and other services in the areas of raw materials, kits, pharmacy IT and through our subsidiary Sanova on its own assortment line.
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and…
Martin Spatz, country manager of QuintilesIMS Austria, the global leader in healthcare market research, discusses the diverse range of services they provide to the two separate entities of the of…
Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive…
Bernhard Wittmann, managing director of Sigmapharm and MoNo, discusses the company’s product portfolio and the diverse tailored services for their partners. Furthermore, he provides an in-depth look into MoNo’s new…
Martin Tiani, CEO of Tiani Spirit, the global leader in Integrating the Healthcare Enterprise (IHE), discusses the importance of interoperability within electronic health information exchange (HIE) and the challenges e-health faces, especially…
Dr. Dietmar Katinger, CEO of Polymun, an Austrian R&D and contract manufacturing company, discusses the challenges CMO companies face within the Austrian market and increasing industry regulations. He also provides…
Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia,…
Dr. Kurt Zatloukal, national node director of the Bio-Banking and Bio-Molecular Resources Research Infrastructure of Austria (BBMRI Austria), discusses the challenges of collaboration between the private and academic pharmaceutical sectors…
Dr. Daniel Wallerstorfer, CEO and founder of Novogenia, a vibrant Austrian genetics company, discusses founding his own company and the innovative services Novogenia provides to ensure genetics are a staple…
Günther Aschenbrenner, managing director of Théa Austria, a specialist French ophthalmology company, discusses the development of the company’s Austrian office since 2011 and how a strong portfolio acquired by Théa…
Daniela Homan, executive director of AmCham Austria, the representative and advocating voice of US companies in Austria, provides an in-depth analysis of the strategies being employed by the chamber and…
Karl Peter Schwarz, general manager of the Austrian affiliate of LEO Pharma, an ambitious Danish company leading the way in innovative dermatology treatments, provides an in-depth look into how global…
See our Cookie Privacy Policy Here
